FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Vanda Sues FDA Over Pending Tradipitant NDA Decision

Vanda Pharmaceuticals sues FDA, seeking an advisory committee meeting to assess the companys pending NDA for tradipitant and its use in treating sympt...

Medical Devices

Zynex TensWave for Pain Cleared

FDA clears a Zynex 510(k) for its TensWave, a transcutaneous electrical nerve stimulation therapy for reducing chronic and acute pain.

latest-news-card-1
Medical Devices

Ventis Emergency Transport Ventilator Cleared

FDA clears a Ventis Medical 510(k) for the VM-2000, an emergency transport ventilator that allows medical personnel to provide respiratory support in ...

latest-news-card-1
Human Drugs

FDA Study Analyzes Provider View of Boxed Warnings

CDER reports on research into how healthcare providers view and use Boxed Warnings when making treatment decisions for their patients.

latest-news-card-1
Human Drugs

Denali Aims for Early 2025 Hunter Syndrome BLA

Denali Therapeutics plans to submit a BLA early next year that will seek accelerated approval for DNL310 (tividenofusp alfa) and its use in treating H...

latest-news-card-1
Human Drugs

Guidance on BIMO Data Technical Specifications

FDA releases a guidance entitled Bioresearch Monitoring Technical Conformance Guide Technical Specifications Document that provides current agency sp...

latest-news-card-1
Federal Register

Roche Cobas Covid/Flu Test EUA Revoked

Federal Register notice: FDA revokes a 2020 emergency use authorization granted to Roche Molecular Systems for the cobas SARS-CoV2 & Influenza A/B nuc...

latest-news-card-1
Federal Register

Intervertebral Body Graft Devices are Class 2

Federal Register notice: FDA classifies intervertebral body graft containment devices into Class 2 (special controls).

latest-news-card-1
Human Drugs

Atlanta Doctors Research Didnt Follow Plan: FDA

FDA warns Atlanta, GA-based physician Julio Flamini about concerns related to investigations at his Clinical Integrative Research Center of Atlanta.

latest-news-card-1
Biologics

Company Illegally Marketing Stem Cells: FDA

FDA warns Coral Gables, FL-based Mother Stem Institute about illegally marketing stromal vascular fraction products derived from donor adipose tissue ...